Hints and tips:
...Eli Lilly will join Pfizer in reporting before the opening bell....
...But returning champions Lilly King and Ryan Murphy were forced to settle for bronze in their respective events on Tuesday....
...(NYT) Blue bump Hedge fund managers Rob Citrone and Paul Tudor Jones have warned an Elizabeth Warren presidency would wreck financial markets....
...Futures for the S&P 500 and Nasdaq 100 were each up 0.4 per cent, while those for the Dow Jones Industrial Average were 0.5 per cent higher....
...Pfizer dropped 1.2 per cent, Merck shed 2 per cent while Eli Lilly and Bristol-Myers Squibb both lost 1 per cent....
...The Dow Jones Industrial Average slipped 0.1 per cent to 21,784 while the Nasdaq Composite edged up 0.1 per cent to 6,398....
...Caterpillar, United Technologies, Biogen and Eli Lilly all reported strong earnings before the bell....
...In earnings, Boeing and Eli Lilly report before the bell, while Microsoft, Facebook, AT&T and Qualcomm come after the market closes....
...By the close of trading, the S&P 500 had advanced 0.6 per cent to 2,159.93, the Dow Jones Industrial Average rose 0.7 per cent to 18,228.30 and the Nasdaq Composite climbed 0.9 per cent to 5,305.71...
...Elsewhere, Eli Lilly shares were in demand after the drugmaker predicted its sales and profits would be higher than expected next year....
...The S&P 500, Dow Jones Industrial Average, the Nasdaq Composite and Russell 2000 all notched new all-time highs on Friday. The Dow, up 0.72 per cent at 19,756.85, is close to the 20,000 milestone....
...Drugmakers Pfizer, Merck and AbbVie rose more than 6 per cent, while Eli Lilly and Amgen climbed more than 5 per cent....
...Shares in Eli Lilly, which have gained 25 per cent so far this year, rose 5.4 per cent to $86.50....
...By close, the S&P 500 added 0.1 per cent to 2,017.46, the Dow Jones Industrial Average rose 0.3 per cent to 17,131.86 and the Nasdaq Composite climbed 0.2 per cent to 4,838.64....
...At the close, the S&P 500 was 0.2 per cent lower at 2,015.93, the Dow Jones Industrial Average edged up 0.1 per cent to 17,251.5, while the Nasdaq Composite slipped 0.5 per cent to 4,728.67....
...Shares in Eli Lilly advanced as much as 5 per cent, but ended the day only 0.8 per cent higher at $71.61....
...The S&P 500 fell 0.3 per cent to 2,102.31, while the Dow Jones Industrial Average lost 0.4 per cent to 17,890.36. The technology heavy Nasdaq Composite decreased 0.2 per cent to 5,112.19....
...Shares in US drugmaker Eli Lilly dipped slightly to $69.23 after it forecast 2015 adjusted earnings in the range of $3.10-$3.20 a share, below expectations of $3.36....
...Milder patients who had received Eli Lilly’s Solanezumab had shown a slowed rate of cognitive decline....
...The benchmark S&P 500 was 0.65 per cent lower at 1,828.75 while the Dow Jones Industrial Average was little changed at 16,040.56....
...Mr Jones says that, as a fresh wave of drug innovation starts to lift growth prospects, tackling big pharma’s image problem is the next challenge....
...However, Procter’s uptick could not keep the Dow Jones Industrial Average in positive territory as the blue-chip index fell fractionally to 15,568.93....
...While distancing himself from such abuses, Trevor Jones, a pharmaceutical industry adviser and non-executive director, argues they reflect past practices....
...The Dow Jones Industrial Average added 0.2 per cent to 15,449.36 and the Nasdaq Composite index gained 0.4 per cent to 3,684.14....
...The Dow Jones Industrial Average lost 0.2 per cent to 15,542.24....
International Edition